In situ gelling systems of ofloxacin: Comparative performance of in vivo precorneal drainage and pharmacokinetic study

Main Article Content

Vrushali S Kashikar
Indrajeet D Gonjari


Our present work describes the formulation and evaluation of an ocular deliver system of ofloxacin based on the concept of temperatureâ€and ionâ€activated in situ gelling system. A combination of Pluronic Fâ€127 and Pluronic Fâ€68 along with
chitosan, (pHâ€sensitive polymer also acts as a permeation enhancer) was used in temperature and pHâ€triggered in situ gelling systems while gellan alone was used in ionâ€activated in situ gelling system. The formulation allows its easy instillation into the eye as a liquid (drops), forms transparent gel, and spreads over the corneal surface. At the formulation pH, transcorneal permeation profile of ofloxacin was comparable to that of in vitro release profile. In situ gelâ€forming ability of the developed systems significantly controls precorneal drainage as studied by gamma scintigraphy. Thus, increased residence time in the
eye would help to increase the ocular bioavailability.The formulation was also found to be nonirritant and well tolerable. Cmax of in situ gelling formulation was found to be 1.5 times higher than marketed eye drops solution at the similar Tmax of 1 h.


Download data is not yet available.

Article Details

How to Cite
Kashikar, V. S., & Gonjari, I. D. (2014). In situ gelling systems of ofloxacin: Comparative performance of in vivo precorneal drainage and pharmacokinetic study. Asian Journal of Pharmaceutics (AJP), 7(1).


Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: An overview. Int J Pharm 2004;269:1â€14.

Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv

Ophthalmol 1982;26:207â€18.

Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic

drug delivery systems–Recent advances. Prog Retin Eye Res


Bourlais CL, Acar LT, Rhodes CT, Sado PA, Leverge R. New ophthalmic

drug delivery systems. Drug Dev Ind Pharm 1995;21:19â€59.

Lin HR, Sung KC. Carbopol/pluronic phase change solutions for

ophthalmic drug delivery. J Control Release 2000;69:379â€88.

Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of

ofloxacin from a pH triggered in situ gelling system. J Control Release


Wilson CG. Assessing ocular drug delivery with lachrimal scintigraphy.

Pharm Sci Technolo Today 1999;2:321â€6.

Rossomondo RM, Carlton WH, Trueblood JH, Thomas RP. A new method

of evaluating lacrimal drainage. Arch Ophthalmol 1972;88:523â€5.

Snibson GR, Greaves JL, Soper ND, Tiffany JM, Wilson CG, Bron AJ.

Ocular surface residence times of artificial tear solutions. Cornea


Greaves JL, Wilson CG, Birmingham AT. Assessment of the precorneal

residence of an ophthalmic ointment in healthy subjects. Br J Clin

Pharmacol 1993;35:188â€92.

Nagarsenker MS, Londhe VY, Nadkarni GD. Preparation and evaluation

of liposomal formulations of tropicamide for ocular delivery. Int J Pharm


Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J Control Release 2006;111:145â€52.

Wei G, Xu H, Ding PT, Li SM, Zheng JM. Thermosetting gels with

modulated gelation temperature for ophthalmic use: The rheological

and gamma scintigraphic studies. J Control Release 2002;83:65â€74.

Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMCâ€based

in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm


Gupta H, Velpandian T, Jain S. Ionâ€and pHâ€activated novel inâ€situ

gel system for sustained ocular drug delivery. J Drug Target


Khan S, Singhara D, Yeole P. Temperature induced in situ gel of lidocaine

hydrochloride for periodontal anesthesia. Indian Drugs 2005;42:519â€24.

Gilbert J, Richardson J, Davies M, Palin K, Hadgraft J. The effect of solutes

and polymers on the gelation properties of Pluronic F127 solutions for

controlled drug delivery. J Control Release 1987;5:113â€8.

Choi H, Jung J, Ryu J, Yoon S, Oh Y, Kim C. Development of in situâ€gelling

and mucoadhesive acetaminophen liquid suppository. Int J Pharm


Gonjari ID, Hosmani AH, Karmarkar AB, Godage AS, Kadam SB,

Dhabale PN. Formulation and evaluation of in situ gelling thermoreversible

mucoadhesive gel of fluconazole. Drug Discov Ther 2009;3:6â€9.

Elâ€Kamel A, Alâ€Dosari H, Alâ€Jenoobi F. Environmentally responsive

ophthalmic gel formulation of carteolol hydrochloride. Drug Deliv


Zignani M, Tabatabay C, Gurny R. Topical semiâ€solid drug delivery: Kinetics

and tolerance of ophthalmic hydrogels. Adv Drug Deliv Rev 1995;16:51â€60.

Sanzgiri Y, Mashi S, Crescenzi V, Callegaro L, Topp M, Stella V. Gellanâ€based

systems for ophthalmic sustained delivery of methylprednisolone.

J Control Release 1993;26:195â€201.

Gunning FP, Greve EL, Bron AM, Bosc JM, Royer JG, George JL, et al., Two

topical carbonic anhydrase inhibitors sezolamide and dorzolamide in

Gelrite vehicle: A multipleâ€dose efficacy study. Graefes Arch Clin Exp

Ophthalmol 1993;231:384â€8.

Johnson DH, Epstein DL, Allen RC, Boysâ€Smith J, Campbell D,

Rosenquist R, et al., A oneâ€year multicenter clinical trial of pilocarpine

gel. Am J Ophthalmol 1984;97:723â€9.

Diamond JP, White L, Leeming JP, Bing Hoh H, Easty DL. Topical 0.3%

ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial

keratitis: A new method for comparative evaluation of ocular drug

penetration. Br J Ophthalmol 1995;79:606â€9.